Balchem Corp
BCPC
ISIN null / Valor 910930
Balchem Corp
UMushroom community rating:
About company
Balchem Corp is a diversified global company that operates across three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. With over 55 years of experience, the company has carved a niche in developing innovative solutions that cater to the health and nutritional needs of both humans and animals around the world. In the realm of Human Nutrition & Health, Balchem offers a range of products that contribute to the wellbeing of people. The Animal Nutrition & Health segment is recognized for being a global leader in choline production and encapsulation technology, offering a comprehensive portfolio of nutrition products for various types of animals, including ruminants, monogastrics, and companion animals. Additionally, the Specialty Products division focuses on the packaging and global distribution of select gases, as well as providing Metalosate® chelated minerals to the agricultural market worldwide. Balchem prides itself on delivering high-quality services and technologies that enable its customers to achieve success, thereby building a strong reputation for achieving results for all stakeholders involved.
Summarized from source with an LLMView SourceSector: IndustrialsLatest Results (19.11.2025):
Balchem Corp's third quarter 2025 financial report shows strong overall performance with record net sales of $267.6 million and steady increases in net earnings, demonstrating robust execution in its specialty nutrients and food ingredient segments. The company reported GAAP net earnings of $40.3 million, adjusted EBITDA of $71.4 million, and free cash flow of $50.7 million, underpinning its growth strategy and market penetration efforts during this period.
Record Net Sales
For Q3 2025, Balchem Corp achieved net sales of $267.6 million, a 5% increase from the prior year quarter, highlighting the company’s capacity to grow revenue through its specialized portfolio and alignment with current market trends.
Earnings and Profitability
The company reported GAAP net earnings of $40.3 million and earnings per share of $1.24, up from $1.03 in the previous year quarter, showcasing a steady growth in profitability alongside record adjusted earnings per share of $1.35.
Operational Efficiency
Adjusted EBITDA remained strong at $71.4 million, and operational cash flows reached $65.6 million, enabling significant investments such as a $36.0 million net repayment on revolving debt, which has reduced net debt to $88.9 million with an overall leverage ratio around 3x.
Strategic Developments
Balchem Corp is moving forward with a new state-of-the-art microencapsulation manufacturing facility in Orange County, NY, aimed at more than doubling capacity. Additionally, promising results from recent sponsored research further affirm the company’s market position and future growth potential in the food and nutrition sectors.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
5085 M
Market cap (USD)
150,194
Daily traded volume (Shares)
164.7 / 162.45
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
